| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytidine deaminase activity | 1.65e-06 | 13 | 37 | 3 | GO:0004126 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 2.00e-05 | 4 | 37 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | deaminase activity | 3.37e-05 | 34 | 37 | 3 | GO:0019239 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 3.37e-05 | 34 | 37 | 3 | GO:0017147 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 4.01e-05 | 36 | 37 | 3 | GO:0016814 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 4.99e-05 | 6 | 37 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 4.46e-04 | 17 | 37 | 2 | GO:0042813 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 5.02e-04 | 18 | 37 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phospholipase C activity | 1.06e-03 | 26 | 37 | 2 | GO:0004435 | |
| GeneOntologyMolecularFunction | phospholipase C activity | 1.31e-03 | 29 | 37 | 2 | GO:0004629 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.50e-03 | 31 | 37 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.70e-03 | 33 | 37 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.74e-03 | 129 | 37 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 2.20e-03 | 140 | 37 | 3 | GO:0099094 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 2.48e-03 | 146 | 37 | 3 | GO:0016810 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.73e-03 | 151 | 37 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 3.61e-03 | 343 | 37 | 4 | GO:0005261 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 5.42e-03 | 193 | 37 | 3 | GO:0015276 | |
| GeneOntologyMolecularFunction | zinc ion binding | 5.52e-03 | 891 | 37 | 6 | GO:0008270 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 5.74e-03 | 197 | 37 | 3 | GO:0022834 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 6.50e-03 | 206 | 37 | 3 | GO:0140030 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular DNA | 1.06e-07 | 6 | 37 | 3 | GO:0044355 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular nucleic acids | 1.06e-07 | 6 | 37 | 3 | GO:0099046 | |
| GeneOntologyBiologicalProcess | DNA cytosine deamination | 6.32e-07 | 10 | 37 | 3 | GO:0070383 | |
| GeneOntologyBiologicalProcess | response to ATP | 7.65e-07 | 40 | 37 | 4 | GO:0033198 | |
| GeneOntologyBiologicalProcess | cytidine to uridine editing | 1.16e-06 | 12 | 37 | 3 | GO:0016554 | |
| GeneOntologyBiologicalProcess | cytidine metabolic process | 1.91e-06 | 14 | 37 | 3 | GO:0046087 | |
| GeneOntologyBiologicalProcess | cytidine catabolic process | 1.91e-06 | 14 | 37 | 3 | GO:0006216 | |
| GeneOntologyBiologicalProcess | cytidine deamination | 1.91e-06 | 14 | 37 | 3 | GO:0009972 | |
| GeneOntologyBiologicalProcess | DNA deamination | 1.91e-06 | 14 | 37 | 3 | GO:0045006 | |
| GeneOntologyBiologicalProcess | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate | 2.93e-06 | 16 | 37 | 3 | GO:0045869 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside metabolic process | 2.93e-06 | 16 | 37 | 3 | GO:0046131 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside catabolic process | 2.93e-06 | 16 | 37 | 3 | GO:0046133 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside catabolic process | 4.26e-06 | 18 | 37 | 3 | GO:0046135 | |
| GeneOntologyBiologicalProcess | regulation of single stranded viral RNA replication via double stranded DNA intermediate | 5.05e-06 | 19 | 37 | 3 | GO:0045091 | |
| GeneOntologyBiologicalProcess | base conversion or substitution editing | 5.05e-06 | 19 | 37 | 3 | GO:0016553 | |
| GeneOntologyBiologicalProcess | single stranded viral RNA replication via double stranded DNA intermediate | 5.93e-06 | 20 | 37 | 3 | GO:0039692 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 6.03e-06 | 146 | 37 | 5 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 6.23e-06 | 147 | 37 | 5 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 6.65e-06 | 149 | 37 | 5 | GO:0051282 | |
| GeneOntologyBiologicalProcess | cellular response to ATP | 6.91e-06 | 21 | 37 | 3 | GO:0071318 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 7.57e-06 | 153 | 37 | 5 | GO:0051208 | |
| GeneOntologyBiologicalProcess | ribonucleoside catabolic process | 1.34e-05 | 26 | 37 | 3 | GO:0042454 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside metabolic process | 1.51e-05 | 27 | 37 | 3 | GO:0006213 | |
| GeneOntologyBiologicalProcess | DNA modification | 2.31e-05 | 31 | 37 | 3 | GO:0006304 | |
| GeneOntologyBiologicalProcess | viral RNA genome replication | 2.54e-05 | 32 | 37 | 3 | GO:0039694 | |
| GeneOntologyBiologicalProcess | nucleoside catabolic process | 2.54e-05 | 32 | 37 | 3 | GO:0009164 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 3.93e-05 | 359 | 37 | 6 | GO:0006874 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule catabolic process | 3.96e-05 | 37 | 37 | 3 | GO:0034656 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 4.08e-05 | 217 | 37 | 5 | GO:0097553 | |
| GeneOntologyBiologicalProcess | glycosyl compound catabolic process | 5.40e-05 | 41 | 37 | 3 | GO:1901658 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 6.14e-05 | 389 | 37 | 6 | GO:0055074 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 6.40e-05 | 392 | 37 | 6 | GO:0070588 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound catabolic process | 7.65e-05 | 46 | 37 | 3 | GO:0072529 | |
| GeneOntologyBiologicalProcess | transposable element silencing | 7.65e-05 | 46 | 37 | 3 | GO:0010526 | |
| GeneOntologyBiologicalProcess | ribonucleoside metabolic process | 8.69e-05 | 48 | 37 | 3 | GO:0009119 | |
| GeneOntologyBiologicalProcess | retrotransposition | 8.69e-05 | 48 | 37 | 3 | GO:0032197 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | 9.19e-05 | 611 | 37 | 7 | GO:0030003 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 9.43e-05 | 259 | 37 | 5 | GO:0051651 | |
| GeneOntologyBiologicalProcess | transposition | 9.83e-05 | 50 | 37 | 3 | GO:0032196 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | 1.03e-04 | 622 | 37 | 7 | GO:0006873 | |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 1.07e-04 | 266 | 37 | 5 | GO:0019722 | |
| GeneOntologyBiologicalProcess | sympathetic ganglion development | 1.12e-04 | 9 | 37 | 2 | GO:0061549 | |
| GeneOntologyBiologicalProcess | response to organophosphorus | 1.19e-04 | 142 | 37 | 4 | GO:0046683 | |
| GeneOntologyBiologicalProcess | negative regulation of viral genome replication | 1.38e-04 | 56 | 37 | 3 | GO:0045071 | |
| GeneOntologyBiologicalProcess | inositol trisphosphate biosynthetic process | 1.70e-04 | 11 | 37 | 2 | GO:0032959 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 1.70e-04 | 11 | 37 | 2 | GO:0071313 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 1.93e-04 | 161 | 37 | 4 | GO:0051592 | |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 2.17e-04 | 166 | 37 | 4 | GO:0014074 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | 2.23e-04 | 705 | 37 | 7 | GO:0055080 | |
| GeneOntologyBiologicalProcess | nucleoside metabolic process | 2.46e-04 | 68 | 37 | 3 | GO:0009116 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | 2.47e-04 | 717 | 37 | 7 | GO:0050801 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 2.66e-04 | 509 | 37 | 6 | GO:0006816 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 2.81e-04 | 14 | 37 | 2 | GO:0071415 | |
| GeneOntologyBiologicalProcess | non-canonical Wnt signaling pathway | 3.55e-04 | 77 | 37 | 3 | GO:0035567 | |
| GeneOntologyBiologicalProcess | inositol trisphosphate metabolic process | 4.19e-04 | 17 | 37 | 2 | GO:0032957 | |
| GeneOntologyBiologicalProcess | ganglion development | 4.70e-04 | 18 | 37 | 2 | GO:0061548 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 5.25e-04 | 88 | 37 | 3 | GO:0071277 | |
| GeneOntologyBiologicalProcess | regulation of viral genome replication | 5.79e-04 | 91 | 37 | 3 | GO:0045069 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound metabolic process | 5.98e-04 | 92 | 37 | 3 | GO:0072527 | |
| GeneOntologyBiologicalProcess | outflow tract morphogenesis | 6.37e-04 | 94 | 37 | 3 | GO:0003151 | |
| GeneOntologyBiologicalProcess | response to caffeine | 6.44e-04 | 21 | 37 | 2 | GO:0031000 | |
| GeneOntologyBiologicalProcess | maintenance of location | 6.69e-04 | 396 | 37 | 5 | GO:0051235 | |
| GeneOntologyBiologicalProcess | glycosyl compound metabolic process | 6.77e-04 | 96 | 37 | 3 | GO:1901657 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | 7.67e-04 | 866 | 37 | 7 | GO:0055082 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | 7.69e-04 | 622 | 37 | 6 | GO:0098771 | |
| GeneOntologyBiologicalProcess | negative regulation of viral process | 8.31e-04 | 103 | 37 | 3 | GO:0048525 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 8.43e-04 | 24 | 37 | 2 | GO:0048015 | |
| GeneOntologyBiologicalProcess | sympathetic nervous system development | 8.43e-04 | 24 | 37 | 2 | GO:0048485 | |
| GeneOntologyBiologicalProcess | negative regulation of necroptotic process | 8.43e-04 | 24 | 37 | 2 | GO:0060546 | |
| GeneOntologyBiologicalProcess | response to magnesium ion | 9.15e-04 | 25 | 37 | 2 | GO:0032026 | |
| GeneOntologyBiologicalProcess | Fc-epsilon receptor signaling pathway | 9.15e-04 | 25 | 37 | 2 | GO:0038095 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 9.79e-04 | 109 | 37 | 3 | GO:1904427 | |
| GeneOntologyBiologicalProcess | negative regulation of programmed necrotic cell death | 9.90e-04 | 26 | 37 | 2 | GO:0062099 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial depolarization | 1.07e-03 | 27 | 37 | 2 | GO:0051900 | |
| GeneOntologyBiologicalProcess | post-anal tail morphogenesis | 1.23e-03 | 29 | 37 | 2 | GO:0036342 | |
| GeneOntologyBiologicalProcess | inositol phosphate biosynthetic process | 1.41e-03 | 31 | 37 | 2 | GO:0032958 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | 1.59e-03 | 981 | 37 | 7 | GO:0019725 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage cytokine production | 1.60e-03 | 33 | 37 | 2 | GO:0060907 | |
| GeneOntologyBiologicalProcess | mitochondrial depolarization | 1.79e-03 | 35 | 37 | 2 | GO:0051882 | |
| GeneOntologyBiologicalProcess | viral genome replication | 1.89e-03 | 137 | 37 | 3 | GO:0019079 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 2.00e-03 | 37 | 37 | 2 | GO:0014808 | |
| GeneOntologyBiologicalProcess | regulation of necroptotic process | 2.00e-03 | 37 | 37 | 2 | GO:0060544 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 2.23e-03 | 39 | 37 | 2 | GO:1903514 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 2.34e-03 | 40 | 37 | 2 | GO:0071312 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 2.54e-03 | 321 | 37 | 4 | GO:0003007 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative catabolic process | 2.59e-03 | 323 | 37 | 4 | GO:1901136 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 2.63e-03 | 154 | 37 | 3 | GO:0051928 | |
| GeneOntologyBiologicalProcess | regulation of programmed necrotic cell death | 2.70e-03 | 43 | 37 | 2 | GO:0062098 | |
| GeneOntologyBiologicalProcess | regulation of viral life cycle | 2.73e-03 | 156 | 37 | 3 | GO:1903900 | |
| GeneOntologyBiologicalProcess | establishment of planar polarity | 2.82e-03 | 44 | 37 | 2 | GO:0001736 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 2.82e-03 | 44 | 37 | 2 | GO:0070296 | |
| GeneOntologyBiologicalProcess | positive regulation of production of molecular mediator of immune response | 2.83e-03 | 158 | 37 | 3 | GO:0002702 | |
| GeneOntologyBiologicalProcess | T cell receptor signaling pathway | 2.93e-03 | 160 | 37 | 3 | GO:0050852 | |
| GeneOntologyBiologicalProcess | establishment of tissue polarity | 2.95e-03 | 45 | 37 | 2 | GO:0007164 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 2.99e-03 | 161 | 37 | 3 | GO:0003206 | |
| GeneOntologyBiologicalProcess | positive regulation of myeloid leukocyte cytokine production involved in immune response | 3.08e-03 | 46 | 37 | 2 | GO:0061081 | |
| GeneOntologyBiologicalProcess | regulation of macrophage cytokine production | 3.35e-03 | 48 | 37 | 2 | GO:0010935 | |
| GeneOntologyCellularComponent | junctional membrane complex | 1.09e-04 | 9 | 37 | 2 | GO:0030314 | |
| Domain | APOBEC_N | 1.56e-06 | 12 | 37 | 3 | PF08210 | |
| Domain | APOBEC_N | 1.56e-06 | 12 | 37 | 3 | IPR013158 | |
| Domain | APOBEC/CMP_deaminase_Zn-bd | 2.57e-06 | 14 | 37 | 3 | IPR016192 | |
| Domain | PLC-gamma | 3.82e-06 | 2 | 37 | 2 | IPR016279 | |
| Domain | Frizzled/SFRP | 3.94e-06 | 16 | 37 | 3 | IPR015526 | |
| Domain | CYT_DCMP_DEAMINASES_1 | 4.77e-06 | 17 | 37 | 3 | PS00903 | |
| Domain | CMP_dCMP_Zn-bd | 4.77e-06 | 17 | 37 | 3 | IPR002125 | |
| Domain | Cytidine_deaminase-like | 4.77e-06 | 17 | 37 | 3 | IPR016193 | |
| Domain | FRI | 7.97e-06 | 20 | 37 | 3 | SM00063 | |
| Domain | - | 9.29e-06 | 21 | 37 | 3 | 1.10.2000.10 | |
| Domain | RyR | 1.14e-05 | 3 | 37 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 1.14e-05 | 3 | 37 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 1.14e-05 | 3 | 37 | 2 | PF06459 | |
| Domain | Ryanrecept_TM4-6 | 1.14e-05 | 3 | 37 | 2 | IPR009460 | |
| Domain | Ryan_recept | 1.14e-05 | 3 | 37 | 2 | IPR013333 | |
| Domain | Frizzled_dom | 1.41e-05 | 24 | 37 | 3 | IPR020067 | |
| Domain | FZ | 1.41e-05 | 24 | 37 | 3 | PS50038 | |
| Domain | Fz | 1.41e-05 | 24 | 37 | 3 | PF01392 | |
| Domain | RIH_assoc | 5.70e-05 | 6 | 37 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 5.70e-05 | 6 | 37 | 2 | IPR013662 | |
| Domain | RYDR_ITPR | 5.70e-05 | 6 | 37 | 2 | PF01365 | |
| Domain | RIH_dom | 5.70e-05 | 6 | 37 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 5.70e-05 | 6 | 37 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 5.70e-05 | 6 | 37 | 2 | IPR015925 | |
| Domain | Ins145_P3_rec | 5.70e-05 | 6 | 37 | 2 | PF08709 | |
| Domain | - | 5.70e-05 | 6 | 37 | 2 | 1.25.10.30 | |
| Domain | MIR | 1.70e-04 | 10 | 37 | 2 | PS50919 | |
| Domain | MIR | 1.70e-04 | 10 | 37 | 2 | PF02815 | |
| Domain | MIR | 1.70e-04 | 10 | 37 | 2 | SM00472 | |
| Domain | MIR_motif | 1.70e-04 | 10 | 37 | 2 | IPR016093 | |
| Domain | Frizzled | 2.08e-04 | 11 | 37 | 2 | IPR000539 | |
| Domain | Frizzled | 2.08e-04 | 11 | 37 | 2 | PF01534 | |
| Domain | Frizzled | 2.08e-04 | 11 | 37 | 2 | SM01330 | |
| Domain | PIPLC_Y_DOMAIN | 3.95e-04 | 15 | 37 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 3.95e-04 | 15 | 37 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 3.95e-04 | 15 | 37 | 2 | IPR015359 | |
| Domain | PI-PLC-Y | 3.95e-04 | 15 | 37 | 2 | PF00387 | |
| Domain | CYT_DCMP_DEAMINASES_2 | 3.95e-04 | 15 | 37 | 2 | PS51747 | |
| Domain | PLipase_C_Pinositol-sp_Y | 3.95e-04 | 15 | 37 | 2 | IPR001711 | |
| Domain | EF-hand_like | 3.95e-04 | 15 | 37 | 2 | PF09279 | |
| Domain | PLCYc | 3.95e-04 | 15 | 37 | 2 | SM00149 | |
| Domain | PI-PLC-X | 5.73e-04 | 18 | 37 | 2 | PF00388 | |
| Domain | PLCXc | 5.73e-04 | 18 | 37 | 2 | SM00148 | |
| Domain | PIPLC_X_DOMAIN | 6.39e-04 | 19 | 37 | 2 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 6.39e-04 | 19 | 37 | 2 | IPR000909 | |
| Domain | SH2 | 1.04e-03 | 101 | 37 | 3 | PF00017 | |
| Domain | - | 1.11e-03 | 25 | 37 | 2 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 1.11e-03 | 25 | 37 | 2 | IPR017946 | |
| Domain | SH2 | 1.33e-03 | 110 | 37 | 3 | SM00252 | |
| Domain | SH2 | 1.37e-03 | 111 | 37 | 3 | PS50001 | |
| Domain | SH2 | 1.41e-03 | 112 | 37 | 3 | IPR000980 | |
| Domain | - | 1.41e-03 | 112 | 37 | 3 | 3.30.505.10 | |
| Domain | EF-hand-dom_pair | 2.42e-03 | 287 | 37 | 4 | IPR011992 | |
| Domain | GPCR_2-like | 6.29e-03 | 60 | 37 | 2 | IPR017981 | |
| Domain | GPCR_2_secretin-like | 6.29e-03 | 60 | 37 | 2 | IPR000832 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 6.49e-03 | 61 | 37 | 2 | PS50261 | |
| Domain | Zinc_finger_PHD-type_CS | 7.34e-03 | 65 | 37 | 2 | IPR019786 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.06e-05 | 178 | 24 | 5 | M2890 | |
| Pathway | REACTOME_MRNA_EDITING_C_TO_U_CONVERSION | 5.80e-05 | 7 | 24 | 2 | MM15412 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOLIPASE_C_GAMMA_PLCG | 5.80e-05 | 7 | 24 | 2 | M27906 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PLCG_PKC_SIGNALING_PATHWAY | 7.73e-05 | 8 | 24 | 2 | M47479 | |
| Pathway | REACTOME_MRNA_EDITING | 9.93e-05 | 9 | 24 | 2 | MM15445 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.23e-04 | 154 | 24 | 4 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.29e-04 | 156 | 24 | 4 | M39475 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.51e-04 | 11 | 24 | 2 | M47958 | |
| Pathway | WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS | 1.85e-04 | 66 | 24 | 3 | M39642 | |
| Pathway | WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS | 2.14e-04 | 13 | 24 | 2 | M39463 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 2.14e-04 | 13 | 24 | 2 | M39589 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 2.50e-04 | 14 | 24 | 2 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 2.50e-04 | 14 | 24 | 2 | M47388 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY | 2.50e-04 | 14 | 24 | 2 | M47383 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY | 2.50e-04 | 14 | 24 | 2 | M47384 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4 | 2.50e-04 | 14 | 24 | 2 | M47834 | |
| Pathway | WP_GPR40_PATHWAY | 2.88e-04 | 15 | 24 | 2 | M39526 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 2.88e-04 | 15 | 24 | 2 | M47385 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY | 2.88e-04 | 15 | 24 | 2 | M47382 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 3.29e-04 | 16 | 24 | 2 | M47449 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY | 3.29e-04 | 16 | 24 | 2 | M47823 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 3.72e-04 | 17 | 24 | 2 | M47387 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN | 3.72e-04 | 17 | 24 | 2 | M47560 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 3.91e-04 | 85 | 24 | 3 | M48315 | |
| Pathway | WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA | 4.47e-04 | 89 | 24 | 3 | M39563 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY | 4.67e-04 | 19 | 24 | 2 | M47596 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.67e-04 | 19 | 24 | 2 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_LGR_RSPO | 4.67e-04 | 19 | 24 | 2 | M47833 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 4.67e-04 | 19 | 24 | 2 | M47733 | |
| Pathway | WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS | 5.18e-04 | 20 | 24 | 2 | M48330 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 5.72e-04 | 21 | 24 | 2 | M47542 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 5.93e-04 | 98 | 24 | 3 | M39731 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 8.14e-04 | 25 | 24 | 2 | M27865 | |
| Pathway | PID_VEGFR1_PATHWAY | 8.81e-04 | 26 | 24 | 2 | M226 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 8.81e-04 | 26 | 24 | 2 | M27053 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 8.98e-04 | 113 | 24 | 3 | M39669 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 9.50e-04 | 27 | 24 | 2 | MM14809 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 1.02e-03 | 28 | 24 | 2 | MM14711 | |
| Pathway | REACTOME_DAP12_SIGNALING | 1.10e-03 | 29 | 24 | 2 | M27171 | |
| Pathway | PID_AR_NONGENOMIC_PATHWAY | 1.25e-03 | 31 | 24 | 2 | M213 | |
| Pathway | REACTOME_DAP12_SIGNALING | 1.25e-03 | 31 | 24 | 2 | MM14886 | |
| Pathway | WP_4P163_COPY_NUMBER_VARIATION | 1.34e-03 | 32 | 24 | 2 | M48083 | |
| Pathway | PID_EPO_PATHWAY | 1.42e-03 | 33 | 24 | 2 | M233 | |
| Pathway | WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION | 1.42e-03 | 33 | 24 | 2 | M39745 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 1.69e-03 | 36 | 24 | 2 | M39699 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 1.98e-03 | 39 | 24 | 2 | M16523 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 2.05e-03 | 325 | 24 | 4 | M12868 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 2.07e-03 | 151 | 24 | 3 | M19428 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 2.48e-03 | 161 | 24 | 3 | M39770 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 2.52e-03 | 44 | 24 | 2 | MM15878 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 2.63e-03 | 45 | 24 | 2 | M47412 | |
| Pathway | WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY | 2.75e-03 | 46 | 24 | 2 | M48317 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 2.75e-03 | 46 | 24 | 2 | M27151 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 2.75e-03 | 46 | 24 | 2 | M47409 | |
| Pathway | PID_PI3KCI_PATHWAY | 2.99e-03 | 48 | 24 | 2 | M141 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 2.99e-03 | 48 | 24 | 2 | MM14589 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 2.99e-03 | 48 | 24 | 2 | M26964 | |
| Pathway | WP_PHOSPHOINOSITIDES_METABOLISM | 3.11e-03 | 49 | 24 | 2 | M40046 | |
| Pathway | KEGG_INOSITOL_PHOSPHATE_METABOLISM | 3.77e-03 | 54 | 24 | 2 | M3896 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 3.77e-03 | 54 | 24 | 2 | M27460 | |
| Pathway | KEGG_NON_SMALL_CELL_LUNG_CANCER | 3.77e-03 | 54 | 24 | 2 | M19818 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 3.77e-03 | 54 | 24 | 2 | MM15202 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 3.77e-03 | 54 | 24 | 2 | MM14871 | |
| Pathway | KEGG_VIBRIO_CHOLERAE_INFECTION | 3.77e-03 | 54 | 24 | 2 | M17906 | |
| Pathway | KEGG_BASAL_CELL_CARCINOMA | 3.90e-03 | 55 | 24 | 2 | M17807 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 3.90e-03 | 55 | 24 | 2 | M47952 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 4.04e-03 | 56 | 24 | 2 | MM14815 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 4.33e-03 | 58 | 24 | 2 | MM14914 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 4.63e-03 | 60 | 24 | 2 | MM14913 | |
| Pathway | WP_WNT_SIGNALING | 4.78e-03 | 61 | 24 | 2 | MM15893 | |
| Pathway | KEGG_GLIOMA | 5.41e-03 | 65 | 24 | 2 | M1835 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 5.88e-03 | 219 | 24 | 3 | M29836 | |
| Pathway | KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION | 5.91e-03 | 68 | 24 | 2 | M16848 | |
| Pathway | WP_NONSMALL_CELL_LUNG_CANCER | 6.60e-03 | 72 | 24 | 2 | M39738 | |
| Pathway | WP_LEPTIN_SIGNALING | 7.33e-03 | 76 | 24 | 2 | M39491 | |
| Pathway | KEGG_VEGF_SIGNALING_PATHWAY | 7.33e-03 | 76 | 24 | 2 | M1749 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 7.33e-03 | 76 | 24 | 2 | M9052 | |
| Pubmed | 4.43e-09 | 4 | 37 | 3 | 27439715 | ||
| Pubmed | 4.43e-09 | 4 | 37 | 3 | 19649317 | ||
| Pubmed | 4.43e-09 | 4 | 37 | 3 | 19344514 | ||
| Pubmed | Structural Features of Antiviral APOBEC3 Proteins are Linked to Their Functional Activities. | 4.43e-09 | 4 | 37 | 3 | 22203821 | |
| Pubmed | 4.43e-09 | 4 | 37 | 3 | 20070863 | ||
| Pubmed | 4.43e-09 | 4 | 37 | 3 | 23097438 | ||
| Pubmed | 1.11e-08 | 5 | 37 | 3 | 25461536 | ||
| Pubmed | Suppression of APOBEC3-mediated restriction of HIV-1 by Vif. | 1.11e-08 | 5 | 37 | 3 | 25206352 | |
| Pubmed | AID and APOBECs span the gap between innate and adaptive immunity. | 1.11e-08 | 5 | 37 | 3 | 25352838 | |
| Pubmed | 2.21e-08 | 6 | 37 | 3 | 22205746 | ||
| Pubmed | Retroelements versus APOBEC3 family members: No great escape from the magnificent seven. | 2.21e-08 | 6 | 37 | 3 | 22912627 | |
| Pubmed | APOBEC3 versus Retroviruses, Immunity versus Invasion: Clash of the Titans. | 2.21e-08 | 6 | 37 | 3 | 22720156 | |
| Pubmed | Structure-guided analysis of the human APOBEC3-HIV restrictome. | 2.21e-08 | 6 | 37 | 3 | 24657093 | |
| Pubmed | 3.87e-08 | 7 | 37 | 3 | 23043100 | ||
| Pubmed | APOBEC3 proteins mediate the clearance of foreign DNA from human cells. | 3.87e-08 | 7 | 37 | 3 | 20062055 | |
| Pubmed | 3.87e-08 | 7 | 37 | 3 | 21835787 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 24227842 | ||
| Pubmed | The assembly of Vif ubiquitin E3 ligase for APOBEC3 degradation. | 9.27e-08 | 9 | 37 | 3 | 25408426 | |
| Pubmed | 1.32e-07 | 10 | 37 | 3 | 23043103 | ||
| Pubmed | Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS. | 1.32e-07 | 10 | 37 | 3 | 20174454 | |
| Pubmed | 1.82e-07 | 11 | 37 | 3 | 12683974 | ||
| Pubmed | HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies. | 1.82e-07 | 11 | 37 | 3 | 22915799 | |
| Pubmed | 4.00e-07 | 14 | 37 | 3 | 35665767 | ||
| Pubmed | 4.00e-07 | 14 | 37 | 3 | 33688799 | ||
| Pubmed | 4.00e-07 | 14 | 37 | 3 | 24424947 | ||
| Pubmed | 4.00e-07 | 14 | 37 | 3 | 36787309 | ||
| Pubmed | Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosis. | 4.00e-07 | 14 | 37 | 3 | 38967302 | |
| Pubmed | 4.00e-07 | 14 | 37 | 3 | 34648731 | ||
| Pubmed | Inducing and measuring apoptotic cell death in mouse pancreatic β-cells and in isolated islets. | 5.00e-07 | 15 | 37 | 3 | 35719268 | |
| Pubmed | 5.00e-07 | 15 | 37 | 3 | 32964455 | ||
| Pubmed | 5.00e-07 | 15 | 37 | 3 | 37707499 | ||
| Pubmed | AdipoRon accelerates bone repair of calvarial defect in diet-induced obesity mice. | 5.00e-07 | 15 | 37 | 3 | 36873496 | |
| Pubmed | 5.00e-07 | 15 | 37 | 3 | 38812551 | ||
| Pubmed | Intestinal transit-amplifying cells require METTL3 for growth factor signaling and cell survival. | 5.00e-07 | 15 | 37 | 3 | 37883185 | |
| Pubmed | ERG K+ channels mediate a major component of action potential repolarization in lymphatic muscle. | 5.00e-07 | 15 | 37 | 3 | 37689781 | |
| Pubmed | 6.15e-07 | 16 | 37 | 3 | 36049479 | ||
| Pubmed | Asprosin-neutralizing antibodies as a treatment for metabolic syndrome. | 6.15e-07 | 16 | 37 | 3 | 33904407 | |
| Pubmed | 7.46e-07 | 17 | 37 | 3 | 30995469 | ||
| Pubmed | 7.46e-07 | 17 | 37 | 3 | 37034992 | ||
| Pubmed | The bone microenvironment invigorates metastatic seeds for further dissemination. | 7.46e-07 | 17 | 37 | 3 | 33878291 | |
| Pubmed | Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all. | 7.46e-07 | 17 | 37 | 3 | 24189052 | |
| Pubmed | Movement-related increases in subthalamic activity optimize locomotion. | 7.46e-07 | 17 | 37 | 3 | 39068661 | |
| Pubmed | Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics. | 8.94e-07 | 18 | 37 | 3 | 20096141 | |
| Pubmed | Vagal sensory neurons mediate the Bezold-Jarisch reflex and induce syncope. | 8.94e-07 | 18 | 37 | 3 | 37914931 | |
| Pubmed | Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction. | 1.10e-06 | 2 | 37 | 2 | 15894801 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 25793864 | ||
| Pubmed | Phospholipase C gamma 2 is essential for specific functions of Fc epsilon R and Fc gamma R. | 1.10e-06 | 2 | 37 | 2 | 12471105 | |
| Pubmed | Molecular species of phospholipids in a murine stem-cell line responsive to erythropoietin. | 1.10e-06 | 2 | 37 | 2 | 8615781 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 9799464 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 9817784 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 12565913 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 9489997 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 9192302 | ||
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 1.10e-06 | 2 | 37 | 2 | 12640042 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 23755966 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 7556644 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 15972651 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 14592949 | ||
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 1.10e-06 | 2 | 37 | 2 | 17118445 | |
| Pubmed | RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle. | 1.10e-06 | 2 | 37 | 2 | 11500519 | |
| Pubmed | Motor neurons with axial muscle projections specified by Wnt4/5 signaling. | 1.68e-06 | 22 | 37 | 3 | 19285468 | |
| Pubmed | 1.93e-06 | 23 | 37 | 3 | 34473953 | ||
| Pubmed | A role for Wnt/beta-catenin signaling in lens epithelial differentiation. | 2.51e-06 | 25 | 37 | 3 | 12812787 | |
| Pubmed | 3.19e-06 | 27 | 37 | 3 | 17804636 | ||
| Pubmed | The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H. | 3.30e-06 | 3 | 37 | 2 | 22013041 | |
| Pubmed | Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging. | 3.30e-06 | 3 | 37 | 2 | 32641479 | |
| Pubmed | APOBEC3 deletion increases the risk of breast cancer: a meta-analysis. | 3.30e-06 | 3 | 37 | 2 | 27602762 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 17015722 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 286744 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 11331309 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 9242641 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 18403125 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 11171121 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 22691411 | ||
| Pubmed | Studies on the restriction of murine leukemia viruses by mouse APOBEC3. | 3.30e-06 | 3 | 37 | 2 | 22666481 | |
| Pubmed | APOBEC3 deletion polymorphism is associated with epithelial ovarian cancer risk among Chinese women. | 3.30e-06 | 3 | 37 | 2 | 24577894 | |
| Pubmed | APOBEC3DE Antagonizes Hepatitis B Virus Restriction Factors APOBEC3F and APOBEC3G. | 3.30e-06 | 3 | 37 | 2 | 27289067 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 24725948 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 18313230 | ||
| Pubmed | APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. | 3.30e-06 | 3 | 37 | 2 | 16648136 | |
| Pubmed | Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice. | 3.30e-06 | 3 | 37 | 2 | 23533681 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 20702647 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 1541833 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 27356895 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 22948152 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 23315078 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 20980520 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 3.30e-06 | 3 | 37 | 2 | 10788707 | |
| Pubmed | Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response. | 3.30e-06 | 3 | 37 | 2 | 25589647 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 284359 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 18434746 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 20617165 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 31801862 | ||
| Pubmed | Apobec-mediated retroviral hypermutation in vivo is dependent on mouse strain. | 3.30e-06 | 3 | 37 | 2 | 39208378 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 31943071 | ||
| Pubmed | PLCγ-dependent mTOR signalling controls IL-7-mediated early B cell development. | 3.30e-06 | 3 | 37 | 2 | 29133930 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 9147651 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 28786489 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 23671100 | ||
| Pubmed | Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions. | 3.30e-06 | 3 | 37 | 2 | 31518043 | |
| Cytoband | 22q13.1 | 4.55e-05 | 85 | 37 | 3 | 22q13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q13 | 1.44e-04 | 330 | 37 | 4 | chr22q13 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 3.42e-07 | 12 | 22 | 3 | 406 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 4.24e-06 | 3 | 22 | 2 | 287 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 7.72e-05 | 11 | 22 | 2 | 286 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 2.39e-04 | 19 | 22 | 2 | 832 | |
| GeneFamily | Phospholipases | 1.18e-03 | 42 | 22 | 2 | 467 | |
| GeneFamily | PHD finger proteins | 5.31e-03 | 90 | 22 | 2 | 88 | |
| GeneFamily | SH2 domain containing | 6.64e-03 | 101 | 22 | 2 | 741 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.02e-02 | 181 | 22 | 2 | 694 | |
| GeneFamily | EF-hand domain containing | 2.88e-02 | 219 | 22 | 2 | 863 | |
| Coexpression | GSE27786_CD8_TCELL_VS_NKTCELL_UP | 3.50e-07 | 200 | 37 | 6 | M4839 | |
| Drug | AC1L1KRB | 2.55e-08 | 54 | 37 | 5 | CID000005621 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 2.57e-06 | 2 | 37 | 2 | ctd:C005147 | |
| Drug | AC1L1CR9 | 5.15e-06 | 21 | 37 | 3 | CID000002023 | |
| Drug | lysosphingomyelin | 5.85e-06 | 160 | 37 | 5 | CID000005263 | |
| Drug | 2-hydroxycarbazole | 7.70e-06 | 3 | 37 | 2 | CID000093551 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 7.70e-06 | 3 | 37 | 2 | CID000080262 | |
| Drug | cis-diammineplatinum(II | 7.70e-06 | 3 | 37 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 7.70e-06 | 3 | 37 | 2 | CID002750949 | |
| Drug | flubendiamide | 7.70e-06 | 3 | 37 | 2 | CID011193251 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 7.70e-06 | 3 | 37 | 2 | CID005748312 | |
| Drug | 8N3-cADPR | 7.70e-06 | 3 | 37 | 2 | CID000127713 | |
| Drug | aminodantrolene | 7.70e-06 | 3 | 37 | 2 | CID009570289 | |
| Drug | Kn 04 | 1.00e-05 | 26 | 37 | 3 | CID000131117 | |
| Drug | XeC compound | 1.04e-05 | 84 | 37 | 4 | CID000005701 | |
| Drug | CB1954 | 1.40e-05 | 29 | 37 | 3 | CID000089105 | |
| Drug | A-30 | 1.54e-05 | 4 | 37 | 2 | CID003028528 | |
| Drug | PCB74 | 1.54e-05 | 4 | 37 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 1.54e-05 | 4 | 37 | 2 | CID006444275 | |
| Drug | Bastadin 10 | 1.54e-05 | 4 | 37 | 2 | CID009589366 | |
| Drug | SC 38249 | 1.54e-05 | 4 | 37 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 1.54e-05 | 4 | 37 | 2 | CID000035682 | |
| Drug | Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; PC3; HT_HG-U133A | 1.68e-05 | 199 | 37 | 5 | 3668_DN | |
| Drug | sevoflurane | 2.51e-05 | 105 | 37 | 4 | CID000005206 | |
| Drug | MBED | 3.84e-05 | 6 | 37 | 2 | CID000129958 | |
| Drug | chloro-m-cresol | 3.84e-05 | 6 | 37 | 2 | CID000012008 | |
| Drug | SKF83742 | 3.84e-05 | 6 | 37 | 2 | CID000130828 | |
| Drug | AC1O528X | 3.84e-05 | 6 | 37 | 2 | CID006475857 | |
| Drug | NSC114784 | 3.84e-05 | 6 | 37 | 2 | CID000419425 | |
| Drug | NSC692750 | 3.84e-05 | 6 | 37 | 2 | CID000078910 | |
| Drug | Clorocruoro Hem | 4.67e-05 | 123 | 37 | 4 | CID003518809 | |
| Drug | Azumoleno | 5.37e-05 | 7 | 37 | 2 | CID000056259 | |
| Drug | mag-indo-1 | 5.37e-05 | 7 | 37 | 2 | CID000131881 | |
| Drug | Br2BAPTA | 5.37e-05 | 7 | 37 | 2 | CID003081001 | |
| Drug | kushenol H | 5.37e-05 | 7 | 37 | 2 | CID005318897 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 5.37e-05 | 7 | 37 | 2 | CID009547999 | |
| Drug | CHEBI:564108 | 5.37e-05 | 7 | 37 | 2 | CID006400637 | |
| Drug | AC1L1G92 | 7.15e-05 | 8 | 37 | 2 | CID000003582 | |
| Drug | lactosyl lysosphingolipid | 9.18e-05 | 9 | 37 | 2 | CID006439268 | |
| Drug | FLA 365 | 9.18e-05 | 9 | 37 | 2 | CID000072776 | |
| Drug | lead compounds | 1.01e-04 | 150 | 37 | 4 | CID000073212 | |
| Drug | BAPTA-AM | 1.06e-04 | 293 | 37 | 5 | CID000002293 | |
| Drug | lindane | 1.12e-04 | 154 | 37 | 4 | CID000000727 | |
| Drug | nonyl acridine orange | 1.15e-04 | 10 | 37 | 2 | CID000115086 | |
| Drug | AC1N38XE | 1.15e-04 | 10 | 37 | 2 | CID004060965 | |
| Drug | PCB 95 | 1.15e-04 | 10 | 37 | 2 | CID000038012 | |
| Drug | CHAPS detergent | 1.23e-04 | 158 | 37 | 4 | CID000107670 | |
| Drug | HMS3267E16 | 1.40e-04 | 62 | 37 | 3 | CID000003668 | |
| Drug | PCB 66 | 1.40e-04 | 11 | 37 | 2 | CID000036185 | |
| Drug | R 478 | 1.40e-04 | 11 | 37 | 2 | CID000084223 | |
| Drug | 8-amino-cADPR | 1.40e-04 | 11 | 37 | 2 | CID003081323 | |
| Drug | Ryanodine | 1.68e-04 | 12 | 37 | 2 | ctd:D012433 | |
| Drug | BAPTA | 1.70e-04 | 324 | 37 | 5 | CID000104751 | |
| Drug | Lopac-P-178 | 1.76e-04 | 67 | 37 | 3 | CID005478935 | |
| Drug | NSC-695672 | 1.76e-04 | 67 | 37 | 3 | CID000393593 | |
| Drug | strontium | 1.84e-04 | 68 | 37 | 3 | CID000104798 | |
| Drug | papaverine | 1.87e-04 | 176 | 37 | 4 | CID000004680 | |
| Drug | NSC299933 | 1.98e-04 | 13 | 37 | 2 | CID000431902 | |
| Drug | A 172 | 2.01e-04 | 70 | 37 | 3 | CID000014025 | |
| Drug | AC1L1D8L | 2.09e-04 | 71 | 37 | 3 | CID000002241 | |
| Drug | bimoclomol | 2.31e-04 | 14 | 37 | 2 | CID009576891 | |
| Drug | NP-EGTA | 2.31e-04 | 14 | 37 | 2 | CID000183793 | |
| Drug | nickel | 2.42e-04 | 552 | 37 | 6 | CID000000934 | |
| Drug | Triamcinolone [124-94-7]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.60e-04 | 192 | 37 | 4 | 2078_DN | |
| Drug | FPL 64176 | 2.66e-04 | 15 | 37 | 2 | CID000003423 | |
| Drug | Gvapspat amide | 2.66e-04 | 15 | 37 | 2 | CID000125015 | |
| Drug | Sulfameter [651-06-9]; Down 200; 14.2uM; PC3; HT_HG-U133A | 2.71e-04 | 194 | 37 | 4 | 5732_DN | |
| Drug | Cinchonine [118-10-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 2.71e-04 | 194 | 37 | 4 | 2789_UP | |
| Drug | Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 2.76e-04 | 195 | 37 | 4 | 5357_DN | |
| Drug | myo-inositol | 2.87e-04 | 811 | 37 | 7 | CID000000892 | |
| Drug | FK-506; Up 200; 1uM; MCF7; HG-U133A | 2.87e-04 | 197 | 37 | 4 | 284_UP | |
| Drug | Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 2265_DN | |
| Drug | Vinpocetine [42971-09-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.87e-04 | 197 | 37 | 4 | 7213_DN | |
| Drug | Lysergol [602-85-7]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.93e-04 | 198 | 37 | 4 | 3261_DN | |
| Drug | Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.93e-04 | 198 | 37 | 4 | 6271_DN | |
| Drug | Etanidazole [22668-01-5]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 2.93e-04 | 198 | 37 | 4 | 6211_DN | |
| Drug | 5253409; Down 200; 17uM; MCF7; HT_HG-U133A_EA | 2.93e-04 | 198 | 37 | 4 | 961_DN | |
| Drug | DM-nitrophen | 3.04e-04 | 16 | 37 | 2 | CID000003083 | |
| Drug | kazinol B | 3.44e-04 | 17 | 37 | 2 | CID000480869 | |
| Drug | reactive blue 2 | 3.81e-04 | 87 | 37 | 3 | CID000656725 | |
| Drug | methylcoumarin | 3.87e-04 | 18 | 37 | 2 | CID000007092 | |
| Drug | AC1L380G | 4.32e-04 | 19 | 37 | 2 | CID000084698 | |
| Drug | AC1MW7VF | 4.32e-04 | 19 | 37 | 2 | CID000414699 | |
| Drug | adenosine diphosphoribose | 4.49e-04 | 92 | 37 | 3 | CID000030243 | |
| Drug | 5-fluoropyrimidine | 4.79e-04 | 20 | 37 | 2 | CID000069605 | |
| Drug | ADP beta S | 5.09e-04 | 96 | 37 | 3 | CID005310996 | |
| Drug | diatrizoate | 5.29e-04 | 21 | 37 | 2 | CID000002140 | |
| Drug | indo-1/AM | 5.29e-04 | 21 | 37 | 2 | CID000123918 | |
| Drug | AC1L1GTT | 5.42e-04 | 233 | 37 | 4 | CID000003837 | |
| Drug | strontium chromate | 5.57e-04 | 99 | 37 | 3 | CID000024599 | |
| Drug | valerate | 6.07e-04 | 102 | 37 | 3 | CID000007991 | |
| Drug | PMEI | 6.93e-04 | 24 | 37 | 2 | CID000451928 | |
| Drug | 6-methoxypurine arabinoside | 6.93e-04 | 24 | 37 | 2 | CID000124757 | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 3.86e-06 | 3 | 34 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 3.86e-06 | 3 | 34 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | serum gamma-glutamyl transferase measurement | 5.56e-04 | 914 | 34 | 6 | EFO_0004532 | |
| Disease | Inflammatory Bowel Diseases | 7.49e-04 | 35 | 34 | 2 | C0021390 | |
| Disease | chronic obstructive pulmonary disease | 1.08e-03 | 688 | 34 | 5 | EFO_0000341 | |
| Disease | Chronic Lymphocytic Leukemia | 1.84e-03 | 55 | 34 | 2 | C0023434 | |
| Disease | Abnormality of chromosome segregation | 2.19e-03 | 60 | 34 | 2 | HP_0002916 | |
| Disease | venous thromboembolism, fibrinogen measurement | 2.72e-03 | 67 | 34 | 2 | EFO_0004286, EFO_0004623 | |
| Disease | Contact hypersensitivity | 3.05e-03 | 71 | 34 | 2 | C0162351 | |
| Disease | Contact Dermatitis | 3.05e-03 | 71 | 34 | 2 | C0011616 | |
| Disease | testosterone measurement | 3.06e-03 | 1275 | 34 | 6 | EFO_0004908 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MCKEPGWFCLIFADE | 521 | Q4AC99 | |
| MCFLSWFCGNRLPAN | 81 | Q96AK3 | |
| MGFPEFADCWENFVD | 136 | Q6NTF7 | |
| MDWFHCNQCFRKDGA | 1 | A8MTL3 | |
| ACEPENLEFSSFMFW | 146 | Q9ULX3 | |
| DCLNIEMPDGSWFCN | 856 | O96028 | |
| EMPDGSWFCNDCRAG | 861 | O96028 | |
| SDVCGMNCFWEAAFR | 91 | Q4G148 | |
| CNFDFLEEPCGWMYD | 646 | O60462 | |
| CPFEKRRDAACVFWD | 321 | Q8IXQ5 | |
| MGCRCIELDCWDGPD | 351 | P16885 | |
| WMDRVLCQGFAFDIP | 116 | P16083 | |
| QDMADFAILPSCCRW | 561 | Q99572 | |
| MEQFNFGWPDSLDCA | 126 | O00144 | |
| AEMCFLSWFCGNQLP | 66 | Q8IUX4 | |
| GTNPDWMFFCCFAGT | 176 | Q9Y6K0 | |
| DICICPNRFDSWAGM | 1081 | Q9Y6J0 | |
| GPVFTEEMWRLACCA | 1596 | Q5TH69 | |
| MRFRFCGDLDCPDWV | 1 | Q9H0A8 | |
| WPEDMECSRFPDCDE | 121 | Q9NPG1 | |
| QERCWDFFPAGDCFR | 5016 | P21817 | |
| AFGFPWPDMLECDRF | 131 | Q96HF1 | |
| MPGFFCDCWPSLEIR | 1 | Q5JUQ0 | |
| MNWFGSNFFRCPEDL | 1 | A1L4L8 | |
| MIGCDNDECPIEWFH | 366 | Q9UK53 | |
| MFCDFTNDLFPWLND | 906 | Q9NTG1 | |
| TWCPADCQFAFMARN | 96 | Q6ZV89 | |
| PEMDAPFWCNQGAAC | 151 | O75503 | |
| MRDPKFLWCAQCSFG | 791 | Q96EP0 | |
| DAFWCFCGFMELVQG | 436 | Q9HA65 | |
| EEPCYLWFVMEFCEG | 306 | Q8TDR2 | |
| WDFPVELCCRPMAFV | 6 | Q7Z392 | |
| MTPAGLSFFQCRWDD | 311 | Q96DV4 | |
| MYQERCWDFFPAGDC | 4846 | Q15413 | |
| MAGFLDNFRWPECEC | 1 | P56557 | |
| CRCIELDCWDGPDGM | 361 | P19174 | |
| AADCWMCQPVARGFV | 111 | Q8N3G9 | |
| FVMFFAPWCGHCQRL | 81 | Q8NBS9 |